NON-EXUDATIVE AGE-RELATED MACULAR DEGENERATION

Clinical trials for NON-EXUDATIVE AGE-RELATED MACULAR DEGENERATION explained in plain language.

Never miss a new study

Get alerted when new NON-EXUDATIVE AGE-RELATED MACULAR DEGENERATION trials appear

Sign up with your email to follow new studies for NON-EXUDATIVE AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Doctors test stem cell eye injections to fight blindness

Disease control Ongoing

This early-stage study is checking if it's safe and possible to treat vision loss by injecting a patient's own bone marrow stem cells directly into the eye. It involves 15 adults who have lost vision from conditions like macular degeneration or diabetic retinopathy. The main goal…

Matched conditions: NON-EXUDATIVE AGE-RELATED MACULAR DEGENERATION

Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

NON-EXUDATIVE AGE-RELATED MACULAR DEGENERATION

Get alerted when new NON-EXUDATIVE AGE-RELATED MACULAR DEGENERATION trials appear

Doctors test stem cell eye injections to fight blindness